Who Moved My Prescription? Part III
A breakdown of the issues surrounding retail pharmacy—and what can be done to address these difficulties in a timely manner.
Who Moved My Prescription? Part II
An analysis of the two main new models for pharmacy—unique direct—to-consumer for brands and cash pay for generics—and what members of industry think about them.
Who Moved My Prescription?
While new forms of pharmacy continue to surface beyond brick-and-mortar retail, a look at what is driving this shift in perspective—and "pharmacies of the future"—is warranted.
Return of Cash Pay for Drugs
The trend is continuing for brands and even for some specialty products.
Breaking the Pharma Industry’s Bundled Pricing Arrangements
How the ‘fight-for-the-dollar’ is coming and likely will impact the bundled pricing of industry stakeholders.
Channel Fragmentation and Diversifying Product Archetypes
New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.